The local market stayed in profit-taking consolidation mode on Thursday, led by oil & gas and technology heavyweights, ignoring the strong performance on North Asian markets sparked by China's stimulus measures. The FBM KLCI slipped 2.06 points to close at 1,671.32, off an early high of 1,672.60 and low of 1,666.19, as losers beat gainers 582 to 525 on moderate turnover of 3.13bn shares worth RM2.83bn.
While stocks remain in consolidation, expectations for further foreign fund inflows amidst the strong ringgit and hopes for further interest rate cuts by key global central banks should underpin sentiment. Immediate index resistance is retained at the high of 1,684, then 1,695, the Dec 2020 high, as tougher resistance. Immediate support will be at 1,650, then the recent correction low of 1,633, with 1,620 and 1,600 acting as stronger supports.
Further rally on Duopharma would aggravate overbought momentum and increase profit-taking resistance, specifically towards the 23.6%FR (RM1.47) and RM1.55, while pullbacks should find supports at the 50%FR (RM1.31) and 61.8%FR (RM1.24). Pharmaniaga is still in base building mode, with chart supports at the lower Bollinger band (36sen) and 23.6%FR (33sen) cushioning downside, while a confirmed breakout above the 38.2%FR (40sen) should aim for the 50%FR (46sen) and 61.8%FR (51sen) ahead.
Source: TA Research - 27 Sept 2024
Chart | Stock Name | Last | Change | Volume |
---|
2024-12-19
CAPITALA2024-12-19
GAMUDA2024-12-19
GAMUDA2024-12-19
GAMUDA2024-12-19
GAMUDA2024-12-19
GAMUDA2024-12-19
HIAPTEK2024-12-19
SAPNRG2024-12-19
SEAL2024-12-19
SEAL2024-12-19
SEAL2024-12-19
SEAL2024-12-18
GAMUDA2024-12-18
GAMUDA2024-12-18
SAPNRG2024-12-18
SAPNRG2024-12-18
SAPNRG2024-12-18
SAPNRG2024-12-17
CENSOF2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
GAMUDA2024-12-17
SAPNRG2024-12-17
SCR2024-12-16
GAMUDA2024-12-16
GAMUDA2024-12-16
GAMUDA2024-12-16
GAMUDA2024-12-16
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
GAMUDA2024-12-13
HIAPTEK2024-12-13
HIAPTEK2024-12-13
SAPNRG2024-12-12
GAMUDA2024-12-12
GAMUDA2024-12-12
GAMUDA2024-12-12
GAMUDA2024-12-12
SAPNRG2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
GAMUDA2024-12-11
SAPNRG2024-12-10
GAMUDA2024-12-10
GAMUDA2024-12-10
GAMUDA2024-12-10
GAMUDA2024-12-10
GAMUDA2024-12-10
GAMUDA2024-12-09
CENSOF2024-12-09
GAMUDA2024-12-09
GAMUDA2024-12-09
GAMUDA2024-12-09
GAMUDA2024-12-09
HIAPTEK2024-12-09
YENHERCreated by sectoranalyst | Dec 19, 2024
Created by sectoranalyst | Dec 19, 2024
Created by sectoranalyst | Dec 19, 2024
Created by sectoranalyst | Dec 19, 2024
Created by sectoranalyst | Dec 18, 2024